FDA Issues Warning Against Rhino Male Enhancement Pills

Washington, D.C.—The FDA issued a warning regarding Rhino male enhancement products due to undeclared and potentially dangerous drug ingredients, according to their press release.

The FDA has received reports of people experiencing chest pain, severe headaches, and extreme drops in blood pressure.

The FDA has identified various Rhino products containing sildenafil and or/tadalafil, the active ingredients in Viagra and Cialis, respectively. These ingredients can cause significant health issues. For example, they can interact with nitrates found in prescription drugs, and lower blood pressure to dangerous levels.

In the press release, the FDA suggested that “Consumers should be on alert for products that offer immediate or quick results and that sound too good to be true.”

Loren Israelsen, president of the United Natural Products Alliance (UNPA), issued a statement in which he said that “Addressing the spiked ingredients issue is a growing industry priority and one that UNPA will be focusing on in 2019.”

Those who have experienced an adverse health effect that may be related to a drug masquerading as a dietary supplement are encouraged to report it through the FDA’s MedWatch Safety Information Program.